R&D personnel work at a shared office space of a chips testing service platform at the Zhangjiang Hi-Tech 895 Incubator in Pudong New Area, east China'sShanghai, on July 8, 2026.
Synthetic biology company Kangma Biotech has benefited greatly from the "ultra-high innovation density" in Zhangjiang Pharma Valley, as all the necessary resources can be found within one kilometer, said the company's founder Guo Min.